Vincent Medical Holdings (1612) Fundamentals 2026 — P/E 4.5x, Revenue Analysis | SniperIQ
Vincent Medical Holdings (1612) is a HK-listed Healthcare company in Medical - Devices with a market capitalization of HK$475M, trading at HK$0.73 on the HKSE. This SniperIQ fundamentals page covers Vincent Medical Holdings's valuation (P/E 4.5x, P/B 0.7x), profitability (net margin 11.2%), revenue (HK$933M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Vincent Medical Holdings's market cap?
Vincent Medical Holdings (1612) has a market capitalization of approximately HK$475M, trading at HK$0.73 on the HKSE. Market cap moves with the live share price.
What is Vincent Medical Holdings's P/E ratio?
Vincent Medical Holdings's trailing twelve-month P/E ratio is 4.5x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Vincent Medical Holdings?
Vincent Medical Holdings runs a net profit margin of 11.2%, a gross margin of 35.1%, and an operating margin of 13.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Vincent Medical Holdings generate?
Vincent Medical Holdings reported revenue of HK$933M for fiscal year 2025, with net income of HK
Does Vincent Medical Holdings pay a dividend?
Vincent Medical Holdings offers a trailing dividend yield of about 6.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Vincent Medical Holdings financially healthy?
Vincent Medical Holdings carries a debt-to-equity ratio of 0.27x and a current ratio of 1.96x, with a market beta of 0.74. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Vincent Medical Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Vincent Medical Holdings (1612) the key facts are: market cap HK$475M, P/E 4.5x, revenue HK$933M, 52-week range 0.64-1.32. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Vincent Medical Holdings's full fundamentals live
Get Vincent Medical Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.